近岸蛋白
(688137)
| 流通市值：29.90亿 | | | 总市值：29.90亿 |
| 流通股本：7017.54万 | | | 总股本：7017.54万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 37,246,747.9 | 146,439,493.07 | 111,854,902.43 | 72,094,559.14 |
| 营业收入 | 37,246,747.9 | 146,439,493.07 | 111,854,902.43 | 72,094,559.14 |
| 二、营业总成本 | 43,448,993.89 | 185,997,982.61 | 131,176,781.29 | 84,803,092.57 |
| 营业成本 | 11,064,674.78 | 48,146,398.72 | 39,328,137.42 | 25,614,277.9 |
| 税金及附加 | 179,682.97 | 1,498,955.9 | 1,060,484.39 | 535,546.95 |
| 销售费用 | 13,106,384.31 | 56,854,063.77 | 40,258,262.1 | 26,113,512.59 |
| 管理费用 | 8,573,174.94 | 43,199,861.37 | 32,290,964.84 | 21,934,529.41 |
| 研发费用 | 15,925,524.66 | 64,062,418.94 | 40,248,363.71 | 26,101,953.29 |
| 财务费用 | -5,400,447.77 | -27,763,716.09 | -22,009,431.17 | -15,496,727.57 |
| 其中:利息费用 | 610,134.74 | 2,543,604.87 | 1,993,226.52 | 1,387,729.81 |
| 其中:利息收入 | 6,984,720.36 | 31,728,189.73 | 24,774,916.38 | 17,216,346.27 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | 267,479.91 | 267,479.91 | 267,479.91 |
| 资产处置收益 | - | 731,409.51 | 731,409.51 | 731,409.51 |
| 资产减值损失(新) | -4,614,810.65 | -33,022,880.96 | -21,976,820.24 | -18,127,681.15 |
| 信用减值损失(新) | -758,207.03 | 1,091,138.04 | 1,283,983.32 | 827,598.93 |
| 其他收益 | 133,609.33 | 636,426.56 | 881,071.31 | 455,821.31 |
| 四、营业利润 | -11,441,654.34 | -69,854,916.48 | -38,134,755.05 | -28,553,904.92 |
| 加:营业外收入 | 19,117.5 | 19,190.16 | 18,846.83 | 17,046.85 |
| 减:营业外支出 | 37,212.46 | 537,840.26 | 386,273.79 | 381,037.07 |
| 五、利润总额 | -11,459,749.3 | -70,373,566.58 | -38,502,182.01 | -28,917,895.14 |
| 减:所得税费用 | -855,381.55 | 7,409,824.98 | -9,642,913.51 | -4,694,324.32 |
| 六、净利润 | -10,604,367.75 | -77,783,391.56 | -28,859,268.5 | -24,223,570.82 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -10,604,367.75 | -77,783,391.56 | -28,859,268.5 | -24,223,570.82 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -10,604,367.75 | -77,783,391.56 | -28,859,268.5 | -24,223,570.82 |
| 扣除非经常损益后的净利润 | -10,603,078.52 | -77,120,244.53 | -32,639,345.14 | -26,684,693.64 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.15 | -1.11 | -0.41 | -0.35 |
| (二)稀释每股收益 | -0.15 | -1.11 | -0.41 | -0.35 |
| 八、其他综合收益 | 126,512.97 | 113,649.11 | 41,526.76 | 12,987.82 |
| 归属于母公司股东的其他综合收益 | 126,512.97 | 113,649.11 | 41,526.76 | 12,987.82 |
| 九、综合收益总额 | -10,477,854.78 | -77,669,742.45 | -28,817,741.74 | -24,210,583 |
| 归属于母公司股东的综合收益总额 | -10,477,854.78 | -77,669,742.45 | -28,817,741.74 | -24,210,583 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |